Mitchell L. Shiffman

Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options.

E. Schiff, G. Everson, K. Kowdley, 2013, The New England journal of medicine.

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

Dieter Häussinger, Coleman Smith, oseph, 2002, The New England journal of medicine.

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis.

M. Shiffman, G. Dusheiko, T. Wright, 2000, The New England journal of medicine.

Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

Huy Trinh, Robert Flisiak, Franck Rousseau, 2011, Gastroenterology.

Induction pegylated interferon alfa-2a and high dose ribavirin do not increase SVR in heavy patients with HCV genotype 1 and high viral loads.

K. Reddy, M. Shiffman, S. Harrison, 2010, Gastroenterology.

Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis

E. Lawitz, N. Ravendhran, S. Flamm, 2023, Viruses.